Teachers Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-117,028
Closed -$378K 3188
2017
Q1
$378K Buy
117,028
+11,067
+10% +$27.2K ﹤0.01% 2666
2016
Q4
$143K Buy
105,961
+29,960
+39% +$39.1K ﹤0.01% 2964
2016
Q3
$119K Hold
76,001
﹤0.01% 2988
2016
Q2
$101K Sell
76,001
-614,930
-89% -$2.88M ﹤0.01% 3039
2016
Q1
$3.64M Buy
690,931
+47,400
+7% +$290K 0.01% 1261
2015
Q4
$5.05M Buy
643,531
+80,360
+14% +$692K 0.01% 1135
2015
Q3
$4.76M Buy
563,171
+52,500
+10% +$484K 0.01% 1140
2015
Q2
$5.59M Buy
510,671
+11,370
+2% +$146K 0.01% 1129
2015
Q1
$6.98M Buy
499,301
+43,400
+10% +$664K 0.01% 1028
2014
Q4
$7.7M Buy
455,901
+205,700
+82% +$3M 0.01% 993
2014
Q3
$3.36M Buy
250,201
+181,300
+263% +$2.16M 0.01% 1293
2014
Q2
$878K Sell
68,901
-2,755
-4% -$28.7K ﹤0.01% 2113
2014
Q1
$852K Buy
71,656
+3,400
+5% +$45.6K ﹤0.01% 2121
2013
Q4
$943K Buy
68,256
+2,390
+4% +$33.8K ﹤0.01% 2041
2013
Q3
$1.15M Buy
65,866
+2,623
+4% +$50.2K ﹤0.01% 1832
2013
Q2
$1.03M Buy
+63,243
New +$1.96M ﹤0.01% 1834

Other funds holding INFI

Teachers Advisors's INFI Position: Q2 2017 in Review

Teachers Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2017, closing a stake of 117,028 shares — an estimated $378K sold.

Teachers Advisors first reported a position in INFI in Q2 2013 and held it in 16 quarters. The position peaked at $7.7M in Q4 2014. 74 funds tracked by Wall St. Rank hold INFI as of Q2 2017.

  • Teachers Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Teachers Advisors sold 117,028 Infinity Pharmaceuticals, Inc. shares in Q2 2017, an estimated $378K.
  • Teachers Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
  • Teachers Advisors's Infinity Pharmaceuticals, Inc. position peaked at $7.7M in Q4 2014.
  • 74 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.